Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marcel Espinosa-Caballero"'
Autor:
Armando Antillón, Alexander H de Vries, Marcel Espinosa-Caballero, José Marcos Falcón-González, David Flores Romero, Javier González-Damián, Fabiola Eloísa Jiménez-Montejo, Angel León-Buitimea, Manuel López-Ortiz, Ricardo Magaña, Siewert J Marrink, Rosmarbel Morales-Nava, Xavier Periole, Jorge Reyes-Esparza, Josué Rodríguez Lozada, Tania Minerva Santiago-Angelino, María Cristina Vargas González, Ignacio Regla, Mauricio Carrillo-Tripp, Mario Fernández-Zertuche, Lourdes Rodríguez-Fragoso, Iván Ortega-Blake
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162171 (2016)
Amphotericin B is the most potent antimycotic known to date. However due to its large collateral toxicity, its use, although long standing, had been limited. Many attempts have been made to produce derivatives with reduced collateral damage. The mole
Externí odkaz:
https://doaj.org/article/55cfd25adb6440f28812f62dbb531ff4
Autor:
Iván Ortega-Blake, M. Cristina Vargas-González, Marcel Espinosa-Caballero, Xavier Periole, Mauricio Carrillo-Tripp, Siewert J. Marrink, Alex H. de Vries
Publikováno v:
Biophysical Journal. 106(2)
Amphotericin B (AmB) has been the worldwide drug of choice for the past 20 years to treat advanced systemic infections caused by a wide variety of fungi. The fact that it presents high mammal toxicity has constrained it to controlled clinical use onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a161571adafc785c85e5ee024c0c2b0f
Autor:
Xavier Periole, Alex H. de Vries, Cristina Vargas-González, Mauricio Carrillo-Tripp, Iván Ortega-Blake, Marcel Espinosa-Caballero, Acione García-González
Publikováno v:
Biophysical Journal. 104(2)
Due to its clinical relevance, the action mechanism of the polyene antibiotic Amphotericin B (AmB) has been studied extensively using both experimental (Venegas-Cotero et al 2003, Kasai et al. 2008) and theoretical (Baginski et al. 2005, Czub et al.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8d97355cf20a8bb13d7fb08b0f3bd35
Autor:
Fabiola Eloisa Jiménez-Montejo, Mario Fernández-Zertuche, Ricardo Magaña, A. Antillón, Manuel López-Ortiz, Rosmarbel Morales-Nava, José Marcos Falcón-González, Jorge Reyes-Esparza, Ignacio Regla, Tania Minerva Santiago-Angelino, David Flores Romero, Javier González–Damián, Alex H. de Vries, Josué Rodríguez Lozada, Lourdes Rodríguez-Fragoso, Iván Ortega-Blake, Mauricio Carrillo-Tripp, María Cristina Vargas González, Marcel Espinosa-Caballero, Xavier Periole, Siewert J. Marrink, Angel León-Buitimea
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162171 (2016)
PLoS ONE
PLoS ONE, 11(9):e0162171. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, 11(9):e0162171. PUBLIC LIBRARY SCIENCE
Amphotericin B is the most potent antimycotic known to date. However due to its large col- lateral toxicity, its use, although long standing, had been limited. Many attempts have been made to produce derivatives with reduced collateral damage. The mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63d6128599b410507e8e7b4eeac436f0
https://doi.org/10.1371/journal.pone.0162171
https://doi.org/10.1371/journal.pone.0162171